Engineers Gate Manager’s Forte Biosciences FBRX Stock Holding History

Engineers Gate Manager’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,427	Closed	-$425K	–	2346
2026 Q1	$425K	Buy	+16,427	New	+$473K	0.01%	1500

Other funds holding FBRX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Engineers Gate Manager's FBRX Position: Q2 2026 in Review

Engineers Gate Manager sold out of Forte Biosciences (FBRX) in Q2 2026, closing a stake of 16,427 shares — an estimated $425K sold.

Engineers Gate Manager first reported a position in FBRX in Q1 2026 and held it in 1 quarter. The position peaked at $425K in Q1 2026. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

Engineers Gate Manager reported no remaining Forte Biosciences position as of Q2 2026 after selling out during the quarter.
Engineers Gate Manager sold 16,427 Forte Biosciences shares in Q2 2026, an estimated $425K.
Engineers Gate Manager first reported a position in Forte Biosciences in Q1 2026 and held it in 1 quarter.
Engineers Gate Manager's Forte Biosciences position peaked at $425K in Q1 2026.
86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.